Choriogonadotropin beta chain precursor en es it fr

Choriogonadotropin beta chain precursor Brand names, Choriogonadotropin beta chain precursor Analogs

Choriogonadotropin beta chain precursor Brand Names Mixture

  • No information avaliable

Choriogonadotropin beta chain precursor Chemical_Formula

C1105H1770N318O336S26

Choriogonadotropin beta chain precursor RX_link

http://www.rxlist.com/cgi/generic/ovidrel.htm

Choriogonadotropin beta chain precursor fda sheet

Choriogonadotropin beta chain precursor msds (material safety sheet)

Choriogonadotropin beta chain precursor Synthesis Reference

No information avaliable

Choriogonadotropin beta chain precursor Molecular Weight

25719.7

Choriogonadotropin beta chain precursor Melting Point

55 oC (Forastieri, H., Ingham, K.C. J. Biol. Chem. 257:7976-7981 (1982))

Choriogonadotropin beta chain precursor H2O Solubility

No information avaliable

Choriogonadotropin beta chain precursor State

Solid

Choriogonadotropin beta chain precursor LogP

-0.258

Choriogonadotropin beta chain precursor Dosage Forms

Solution (Subcutaneous Injection)

Choriogonadotropin beta chain precursor Indication

For the treatment of female infertility

Choriogonadotropin beta chain precursor Pharmacology

Choriogonadotropin alfa is used to treat female infertility, Choriogonadotropin alfa stimulates late follicular maturation and resumption of oocyte meiosis, and initiates rupture of the pre-ovulatory ovarian follicle. Ovidrel is an analogue of Luteinizing Hormone (LH) and binds to the LH/hCG receptor of the granulosa and theca cells of the ovary to effect these changes in the absence of an endogenous LH surge.

Choriogonadotropin beta chain precursor Absorption

No information avaliable

Choriogonadotropin beta chain precursor side effects and Toxicity

No information avaliable

Choriogonadotropin beta chain precursor Patient Information

No information avaliable

Choriogonadotropin beta chain precursor Organisms Affected

Humans and other mammals